Lexaria Bioscience Corp. (LEXX)
NASDAQ: LEXX · Real-Time Price · USD
2.230
+0.020 (0.91%)
Dec 20, 2024, 4:00 PM EST - Market closed
Lexaria Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is September - August.
Millions USD. Fiscal year is Sep - Aug.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Aug '24 Aug 31, 2024 | Aug '24 Aug 31, 2024 | Aug '23 Aug 31, 2023 | Aug '22 Aug 31, 2022 | Aug '21 Aug 31, 2021 | Aug '20 Aug 31, 2020 | 2019 - 2015 |
| Net Income | -5.8 | -5.8 | -6.66 | -7.27 | -4.03 | -3.93 | Upgrade
|
| Depreciation & Amortization | 0.11 | 0.11 | 0.19 | 0.14 | 0.15 | 0.15 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.06 | 0.06 | 0.11 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 0.07 | 0.07 | 0.22 | 0.76 | 0.17 | 0.04 | Upgrade
|
| Stock-Based Compensation | 0.49 | 0.49 | 0.17 | 1.95 | 1.28 | 1.41 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.01 | 0.01 | - | - | 0.05 | 0.05 | Upgrade
|
| Other Operating Activities | -0.01 | -0.01 | -0.05 | -0.12 | -0.15 | -0.13 | Upgrade
|
| Change in Accounts Receivable | -0.04 | -0.04 | 0.03 | -0.14 | 0.19 | -0.09 | Upgrade
|
| Change in Inventory | - | - | 0.04 | -0 | 0.1 | 0 | Upgrade
|
| Change in Accounts Payable | 0.83 | 0.83 | 0.09 | 0.05 | 0.01 | -0.05 | Upgrade
|
| Change in Unearned Revenue | 0 | 0 | - | - | -0.04 | 0.04 | Upgrade
|
| Change in Other Net Operating Assets | -0.69 | -0.69 | -0.01 | -0.26 | -0.19 | -0.1 | Upgrade
|
| Operating Cash Flow | -4.96 | -4.96 | -5.88 | -4.88 | -3.99 | -2.62 | Upgrade
|
| Capital Expenditures | -0.04 | -0.04 | -0.03 | -0.05 | - | - | Upgrade
|
| Sale of Property, Plant & Equipment | - | - | - | - | 0.27 | - | Upgrade
|
| Sale (Purchase) of Intangibles | -0.15 | -0.15 | -0.14 | -0.13 | -0.08 | -0.03 | Upgrade
|
| Investment in Securities | - | - | - | - | - | 0.01 | Upgrade
|
| Investing Cash Flow | -0.19 | -0.19 | -0.17 | -0.18 | 0.19 | -0.03 | Upgrade
|
| Long-Term Debt Issued | - | - | - | - | - | 0.03 | Upgrade
|
| Long-Term Debt Repaid | - | - | - | -0.04 | -0.07 | -0.04 | Upgrade
|
| Total Debt Repaid | - | - | - | -0.04 | -0.07 | -0.04 | Upgrade
|
| Net Debt Issued (Repaid) | - | - | - | -0.04 | -0.07 | -0.01 | Upgrade
|
| Issuance of Common Stock | 10.32 | 10.32 | 1.59 | - | 13.49 | 2.67 | Upgrade
|
| Financing Cash Flow | 10.32 | 10.32 | 1.59 | -0.04 | 13.42 | 2.65 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0.02 | -0.02 | - | - | - | - | Upgrade
|
| Net Cash Flow | 5.15 | 5.15 | -4.46 | -5.1 | 9.62 | 0.01 | Upgrade
|
| Free Cash Flow | -5 | -5 | -5.91 | -4.93 | -3.99 | -2.62 | Upgrade
|
| Free Cash Flow Margin | -1077.38% | -1077.38% | -2614.84% | -1929.75% | -552.02% | -831.91% | Upgrade
|
| Free Cash Flow Per Share | -0.40 | -0.40 | -0.89 | -0.84 | -0.91 | -0.94 | Upgrade
|
| Cash Income Tax Paid | 0.01 | 0.01 | 0.01 | -0 | -0.02 | -0.01 | Upgrade
|
| Levered Free Cash Flow | -2.98 | -2.98 | -3.6 | -2.3 | -2.37 | -1.21 | Upgrade
|
| Unlevered Free Cash Flow | -2.98 | -2.98 | -3.6 | -2.3 | -2.37 | -1.21 | Upgrade
|
| Change in Net Working Capital | -0.16 | -0.16 | -0.23 | 0.08 | 0.16 | 0.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.